Financhill
Buy
57

ARQT Quote, Financials, Valuation and Earnings

Last price:
$13.82
Seasonality move :
-16.21%
Day range:
$13.51 - $13.98
52-week range:
$7.86 - $17.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.06x
P/B ratio:
11.50x
Volume:
1.7M
Avg. volume:
2M
1-year change:
47.96%
Market cap:
$1.6B
Revenue:
$196.5M
EPS (TTM):
-$1.04

Earnings Data

Next earnings date for ARQT
Aug 14
2025
Most recent earnings per share
-$0.20
Beat by $0.01
(May 6/2025)
Consensus Estimate
-$0.21
(May 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ARQT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $80.7M -- -- -$0.12 --
08/14/2025 Q2 $72.7M -- -- -$0.16 --
05/06/2025 Q1 $62.5M $65.8M -$0.20 -$0.21 $0.01
02/25/2025 Q4 $60.5M $71.4M -$0.09 -$0.26 $0.17
11/06/2024 Q3 $37.3M $44.8M -$0.33 -$0.43 $0.10
08/14/2024 Q2 $29.1M $30.9M -$0.42 -$0.53 $0.11
05/14/2024 Q1 $15.1M $49.6M -$0.32 -$0.73 $0.41
02/27/2024 Q4 $11.4M $13.5M -$0.72 -$0.80 $0.08
11/03/2023 Q3 -- -- -$0.73 -$0.91 $0.18
08/08/2023 Q2 -- -- -$1.16 -$1.25 $0.09
05/09/2023 Q1 -- -- -$1.31 -$1.26 -$0.05
02/28/2023 Q4 -- -- -$1.18 -$1.44 $0.26
11/08/2022 Q3 -- -- -$1.89 -$1.75 -$0.14
08/04/2022 Q2 -- -- -$1.31 -$1.42 $0.11
05/05/2022 Q1 -- -- -$1.27 -- --
02/22/2022 Q4 -- -- -$1.42 -- --
11/04/2021 Q3 -- -- -$1.14 -- --
08/05/2021 Q2 -- -- -$0.84 -- --
05/06/2021 Q1 -- -- -$0.76 -- --
02/16/2021 Q4 -- -- -$0.79 -- --
11/05/2020 Q3 -- -- -$1.01 -- --
08/11/2020 Q2 -- -- -$0.94 -- --
05/12/2020 Q1 -- -- -$1.15 -- --
12/31/2019 Q4 -- -- -$0.36 -- --
09/30/2019 Q3 -- -- -$0.80 -- --
06/30/2019 Q2 -- -- -$0.46 -- --
03/31/2019 Q1 -- -- -$0.37 -- --
12/31/2018 Q4 -- -- -$0.31 -- --

Arcutis Biotherapeutics Earnings Questions

  • How Much did Arcutis Biotherapeutics Generate in Revenue Last Quarter?

    Arcutis Biotherapeutics reported $65.8M worth of top line sales in its most recent quarter.

  • Did Arcutis Biotherapeutics Beat Earnings Last Quarter?

    Arcutis Biotherapeutics announced earnings per share of -$0.20 which represents a beat of analyst forecast a -$0.21 per share.

  • Is Arcutis Biotherapeutics Profitable?

    Arcutis Biotherapeutics reported $57M that represents $0.45 per share over the last quarter.

  • What is the Analyst Consensus for Arcutis Biotherapeutics EPS Next Year?

    Arcutis Biotherapeutics's earnings are forecast to decrease from -$1.16 per share to -$1.34 per share next year representing a decrease of -52.73%.

  • When is Arcutis Biotherapeutics's Earnings Date?

    Arcutis Biotherapeutics's next earnings date is August 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Robinhood Stock Keep Going Up?
Will Robinhood Stock Keep Going Up?

Commission-free online brokerage Robinhood (NASDAQ:HOOD) has served up massive gains…

Where Will Hershey Stock Be In 1 Year?
Where Will Hershey Stock Be In 1 Year?

Chocolate stocks used to be the epitome of sleepy stability,…

Where Will KNOT Stock Be In 1 Year?
Where Will KNOT Stock Be In 1 Year?

In the case of KNOT Offshore Partners (KNOP), most headlines…

Stock Ideas

Buy
63
Is NVDA Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 53x

Buy
60
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 42x

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
92
BGL alert for Jul 3

Blue Gold [BGL] is down 20.3% over the past day.

Sell
18
CNC alert for Jul 3

Centene [CNC] is down 1.3% over the past day.

Sell
12
MOH alert for Jul 3

Molina Healthcare [MOH] is up 0.3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock